Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dexamfetamine |
Is a |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Amfetamine aspartate (substance) |
Is a |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Amfetamine sulfate (substance) |
Is a |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Lisdexamfetamine (substance) |
Is a |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Levamphetamine (substance) |
Is a |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Dimetamphetamine measurement |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Measurement of amphetamine in serum specimen |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
2 |
Chlorphentermine measurement |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Urine methylenedioxyamphetamine measurement |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Quantitative measurement of mass concentration of amfetamine in serum or plasma specimen using gas chromatography mass spectrometry technique (procedure) |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
2 |
Quantitative measurement of mass concentration of amfetamine and metamfetamine in urine specimen using gas chromatography mass spectrometry technique (procedure) |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Urine methamphetamine measurement |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Methamphetamine measurement |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Methylenedioxymethamphetamine measurement (procedure) |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Fluid sample amphetamine measurement (procedure) |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
2 |
Measurement of amfetamine in meconium specimen using gas chromatography mass spectrometry |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
2 |
Levo-methamphetamine measurement |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Urine amphetamine measurement |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
2 |
Measurement of methylenedioxymethamphetamine and methylenedioxyamphetamine (procedure) |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Amphetamine measurement |
Component |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Measurement of 3,4-methylenedioxymethamphetamine in urine |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Methylenedioxyamphetamine measurement |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Ethylamphetamine measurement (procedure) |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Product containing amfetamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Amphetamine/dextroamphetamine 25mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Amphetamine/dextroamphetamine 5mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Amphetamine/dextroamphetamine 30mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Product containing amfetamine and dexamfetamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
2 |
Amphetamine/dextroamphetamine 15mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Amphetamine/dextroamphetamine 10mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Serum dexamfetamine measurement (procedure) |
Component |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Amphetamine/dextroamphetamine 20mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Lisdexamfetamine dimesylate (substance) |
Is a |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Amfetamine sulfate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Levamphetamine (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Amfetamine aspartate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
|
Product containing amfetamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Product containing only amfetamine and dexamfetamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
2 |
Product containing only amfetamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Amfetamine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Depressive disorder caused by amphetamine |
Causative agent (attribute) |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Amphetamine intoxication |
Causative agent (attribute) |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Amphetamine-induced sexual dysfunction |
Causative agent (attribute) |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
2 |
abus d'amphétamine |
Causative agent (attribute) |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Amphetamine abuse, continuous |
Causative agent (attribute) |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Amphetamine abuse, episodic |
Causative agent (attribute) |
False |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Amphetamine-induced anxiety disorder |
Causative agent (attribute) |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
2 |
Amphetamine dependence (disorder) |
Causative agent (attribute) |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Psychotic disorder caused by amphetamine |
Causative agent (attribute) |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Amfetamine-induced mood disorder (disorder) |
Causative agent (attribute) |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Fluid sample amphetamine measurement (procedure) |
Component |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Measurement of amphetamine in serum specimen |
Component |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Measurement of amfetamine in meconium specimen using gas chromatography mass spectrometry |
Component |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Quantitative measurement of mass concentration of amfetamine in serum or plasma specimen using gas chromatography mass spectrometry technique (procedure) |
Component |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Urine amphetamine measurement |
Component |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |
Amphetamine intoxication delirium (disorder) |
Causative agent (attribute) |
True |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Inferred relationship |
Some |
1 |